Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Biora Therapeutics Announces Stock Offering Introduction SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares of the Company’s common stock at an offering price of $4.025 per share…

Read More

Unleashing the Power of CervoMed: Join Us for an Exciting Oral Presentation at the 8th International Lewy Body Dementia Conference!

CervoMed Inc. Announces Presentation of RewinD-LB Phase 2b Study Data at ILBDC Conference Topline Data Expected in December 2024 BOSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company specializing in treatments for age-related neurologic disorders, has disclosed that they will be sharing detailed safety and efficacy results from the completed…

Read More

Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart in Type 1 Diabetes Patients Undergoing Islet Transplantation

Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart Breakthrough in Type 1 Diabetes Patients Undergoing Islet Transplantation Diabetes has been a prevalent health issue affecting millions of people worldwide, with Type 1 Diabetes (T1D) being a particularly challenging condition to manage. However, a recent development by Eledon Pharmaceuticals has sparked hope and excitement…

Read More

Plus Therapeutics Presents Leptomeningeal Metastases Programs at 2024 SNO Annual Meeting in Houston, Texas

Company to Present Results from Phase 1 Clinical Trial of Rhenium (186Re) Obisbemeda for Leptomeningeal Metastases AUSTIN, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for CNS cancers, will be presenting data at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting in Houston, Texas….

Read More

Uncovering the Truth: Light Wonder Inc. Under Investigation for Possible Securities Law Violations – Reach Out to Levi Korsinsky for More Information – LNw

The Impact of the Light & Wonder Investigation Introduction Recently, Levi & Korsinsky announced an investigation into Light & Wonder, Inc. to determine if there have been any violations of federal securities laws. This investigation comes on the heels of a lawsuit filed by Aristocrat Technologies against Light & Wonder, Inc. in February of 2024….

Read More

Breaking Barriers: Beyond Oil Makes Strides in Eastern Europe with 16-Ton Order from Franchisee of Popular Fast Food Chain

Order Represents Major Milestone in Advancing Beyond Oil’s Global Expansion Embracing a Healthier Future With the rising concerns over health risks associated with fried foods, the innovative strides taken by Beyond Oil Ltd. are nothing short of groundbreaking. By focusing on reducing these risks, the company is not only revolutionizing the food-tech industry but also…

Read More

Attention SIGA Shareholders and Investors: Important Update on SIGA Technologies Inc. Investigation – Contact Levi & Korsinsky for Assistance

Investigation Commenced for SIGA Technologies, Inc. Violations New York, NY / ACCESSWIRE / October 29, 2024 / Levi & Korsinsky Investigation Details Levi & Korsinsky has recently announced that an investigation has been initiated regarding SIGA Technologies, Inc. The investigation focuses on potential violations of federal securities laws by SIGA Technologies, Inc. (NASDAQ:SIGA). The probe…

Read More

Corning Crushes Third Quarter Expectations and Sets Sights on $3 Billion in Annual Sales by 2026

Corning Incorporated Announces Strong Third-Quarter 2024 Results By: Your Name Corning Incorporated (NYSE: GLW) has just released their third-quarter 2024 results, showcasing another quarter of impressive growth. Wendell P. Weeks, the chairman and CEO of Corning, expressed his satisfaction with the company’s performance, noting that third-quarter core sales grew by 8% to $3.73 billion. Additionally,…

Read More